---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-039037"
form_type: "8-K"
ticker: "INGN"
cik: "0001294133"
company_name: "Inogen Inc"
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:49:24.666593+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Inogen Q2 revenue down 19% to $83.6M; net loss widens to $9.8M

## Summary
- Total revenue $83.6M, down 19.1% YoY; GAAP net loss $9.8M vs $3.4M loss year ago.
- Adjusted net loss $5.8M; Adjusted EBITDA loss $3.2M (vs positive $3.2M in Q2 2022).
- Entered agreement to acquire Physio-Assist to add airway clearance market opportunity.
- Introduced Inogen Rove 6 portable oxygen concentrator with 8-year expected service life.
- Cash, cash equivalents and marketable securities $170.1M; no debt outstanding.

## SEC filing metadata
- accession: 0000950170-23-039037
- form_type: 8-K
- ticker: INGN
- cik: 0001294133
- company_name: Inogen Inc
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1294133/000095017023039037/0000950170-23-039037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1294133/000095017023039037/ingn-20230807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-039037
- JSON: https://secwatch.observer/filing/0000950170-23-039037.json
- Plain text: https://secwatch.observer/filing/0000950170-23-039037.txt

## Key facts
- Earnings Releases
  Inogen Inc reported second quarter ended June 30, 2023 results: net income Adjusted net loss of $5.8 million.
  - Period: second quarter ended June 30, 2023
  - Net income: Adjusted net loss of $5.8 million
  - Result: reported results
  source text: Adjusted net loss was $5.8 million compared to Adjusted net loss of $0.4 million in the second quarter of 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1294133/000095017023039037/0000950170-23-039037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.